Visiongain has published a new report entitled the Hospital Bed Market Report 2022-2032: Forecasts by Application (Non Intensive Care Beds, Intensive Care Beds), by Type (Manual, Semi-Electric, Electric), by Hospital Type (Publicly Owned, Not-for-Profit, Privately Owned, For-Profit), by Type of Care (Curative, Rehabilitative, Long Term, Psychiatric, Maternity), by End-user (Hospitals, Home Care, Settings, Elderly, Facilities) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios.
The size of the wood furniture industry is favored by improved patient comfort and flexibility
In 2019, the wood material category accounted for more than 22.5 percent of the medical furniture market. For effective equipment storage, government hospitals use a range of wooden seats, wooden compartments, beds, and cupboards. Preferences for wooden furniture become advantageous for market expansion due to the restricted number of resources in public and government hospitals. Wooden chairs enhance patient comfort and flexibility, allowing for better relaxation, resulting in a higher adoption rate. Changing environmental circumstances, on the other hand, have an impact on the material and may cause patient pain, limiting market demand to some extent.
Download Exclusive Sample of Report @ https://www.visiongain.com/report/hospital-bed-market-2022/#download_sampe_div
One of the major challenges expected to stifle the target market's growth is the high cost of technologically enhanced furnishings. Furthermore, the long lifespan and durability of these types of furniture discourages repeat purchases, which is likely to impede worldwide market growth throughout the projection period.
How has COVID-19 had a significant negative impact on the Hospital Bed Market?
The monetary effects of the early pandemic have started to recalibrate as the country's organizations resume. Likewise, with the remainder of the economy, the wellbeing area saw a sharp drop in incomes and work at the beginning of COVID-19 in the spring of 2020. Wellbeing administrations usage dropped sharply as suppliers dropped elective consideration and patients rehearsing social removing stayed away from wellbeing offices. Usage of wellbeing administrations has remained to some degree lower than anticipated in light of use levels in years before the pandemic and wellbeing area work stays underneath pre-pandemic levels.
The quick and direct expected effect of COVID-19 has effectively brought about a huge number of lives lost and critical gradual expense for the medical care framework. Nonetheless, as has as of now been reported,2 3 an unmistakable chance exists that the quantity of lives lost has been downplayed. At whatever year, the quantity of individuals that bite the dust in the United States follows a moderately steady bend that changes typically throughout the year. In 2020, the United States has strayed perceptibly from this bend. While the immediate effect of COVID-19 has effectively been significant, extra layers of deferred or backhanded effect can possibly predominate the quick impacts. These extra layers of effect connected with COVID-19 could result in $125 billion to $200 billion in gradual yearly US wellbeing framework cost.
How this Report Will Benefit you?
Visiongain’s 521-page report provides 339 tables and 310 charts/graphs. Our new study is suitable for anyone requiring commercial, in-depth analyses for the global hospital bed market, along with detailed segment analysis in the market. Our new study will help you evaluate the overall global and regional market for Hospital Bed. Get the financial analysis of the overall market and different segments including application, bed type, hospital type, care type and capture higher market share. We believe that high opportunity remains in this fast-growing hospital bed market. See how to use the existing and upcoming opportunities in this market to gain revenue benefits in the near future. Moreover, the report would help you to improve your strategic decision-making, allowing you to frame growth strategies, reinforce the analysis of other market players, and maximise the productivity of the company.
What are the current market drivers?
Rising Numbers of Private Hospitals
The number of private hospitals has been steadily increasing, particularly in poor and emerging countries, which is likely to boost market development throughout the forecast period. The expansion of the hospital furniture industry is aided by an increase in private hospital healthcare spending. Regulatory authorities in growing economies such as China have particular laws and regulations governing healthcare infrastructure, which leads to the growth of hospital infrastructure and the provision of higher-quality medical services to patients. Due to rising sickness rates, people's preference for hospitals stimulates demand for medical furnishings, propelling the business forward.
As a result of the worrisome rise in the frequency of chronic illnesses throughout the world, the number of hospital admissions has surged significantly. Government funding for hospitals is frequently included in healthcare budgetary allocations, which might provide additional opportunities for investors in the hospital furniture sector. The worldwide market for medical furniture will be driven by a growing patient pool due to the rising frequency of chronic illnesses. Changes in lifestyle, as well as rising patterns of illnesses linked to a sedentary and sluggish lifestyle, have increased the likelihood of chronic diseases and health difficulties, necessitating therapeutic interventions and health monitoring. These factors will drive the need for medical furniture such as stretchers, trolleys, and beds, allowing the medical furniture sector to develop dramatically and flourish in the next years.
Get Detailed TOC @ https://www.visiongain.com/report/hospital-bed-market-2022/#download_sampe_div
Where are the market opportunities?
The demand for easy-to-manage quarantine beds is fuelled by the Coronavirus pandemic
Manufacturers are profiting on the unusual demand for mattresses and partitions as the COVID-19 cases in India continue to increase. For example, hospitals are cash-strapped as a result of the large number of COVID-19 patients. As a result, manufacturers are offering mattresses that are both affordable and easy to install. Manufacturers are scrambling to expand their capacity in order to fulfil the growing demand created by the coronavirus outbreak. This has aided manufacturers in establishing long-term business relationships with hospitals and will continue to aid manufacturers in establishing long-term contractual relationships with hospitals in the future. Companies have been working around the clock to provide innovative hospital furniture solutions that are the result of extensive research and development. They're working on COVID quarantine beds that are simple to store, operate, and travel.
A High Patient-To-Facility Ratio Creates Revenue Opportunities
Manufacturers in the hospital furniture industry have concentrated their inventions on providing maximum patient comfort and safety. Companies are boosting their production capacities in order to provide hassle-free furniture and equipment availability, even on short notice. Another important feature of furniture quality assurance is that it aids producers in gaining regional and worldwide reputation.
The major players operating in the hospital bed market are GF Health Products, Inc., Getinge AB, Hill-Rom Holdings, Inc., Invacare Corporation, Malvestio S.P.A, Stryker Corporation, Savaria Corporation, Antano Group, Savion Industries, Stiegelmeyer GmbH & Co., Amico Corporation, Medline Industries, LINET Spol S.R.O, Merivaara Corporation, Paramount Bed Holdings Co. Ltd., Midmark Corporation, Famed Zywiec Sp Zo. O, Gendron Inc., Hard Manufacturing Co, Inc., Umano Medical Inc., These major players operating in this market have adopted various strategies comprising M&A, investment in R&D, collaborations, partnerships, regional business expansion, and new product launch.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Hospital bed market and leading companies. You will find data, trends and predictions.
Find more Visiongain research reports on Pharma Medical Devices; click on the following links:
Medical Device Contract Manufacturing Market
Artificial Intelligence (AI) in Drug Discovery Market
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: dev.visavadia@visiongain.com
Visiongain is one of the fastest growing and most innovative, independent, market intelligence around, the company publishes hundreds of market research reports which it adds to its extensive portfolio each year. These reports offer in-depth analysis across 18 industries worldwide. The reports cover a 10-year forecast, are hundreds of pages long, with in depth market analysis and valuable competitive intelligence data. Visiongain works across a range of vertical markets, which currently can influence one another, these markets include automotive, aviation, chemicals, cyber, defense, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors. Our customized and syndicated market research reports mean that you can have a bespoke piece of market intelligence customized to your very own business needs.
Contact: Dev Visavadia PR at Visiongain Reports Limited Tel: + 44 0207 336 6100 Email: dev.visavadia@visiongain.com
As we close in on the final quarter of 2022, investors are looking for an answer to one question: was June’s low the bottom for stocks, or do they have more room to fall? It’s a serious question, and there may be no easy answer. Markets are facing a series of headwinds, from the high inflation and rising interest rates that we’ve grown familiar with to an increasingly strong dollar that will put pressure on the upcoming Q3 earnings. Weighing in on current conditions from Charles Schwab, the $8 t
Berkshire Hathaway is on pace to collect $6.07 billion in dividend income over the next 12 months. Just five holdings will account for 71% of total payouts.
Nio (NYSE: NIO) reported increasing losses in its second-quarter earnings report this week, but investors are shrugging that off, sending shares soaring Friday morning. Although its profit margins have been on a downward trend, new models being launched could turn that around in the coming years. Consumer prices in China increased at a slower pace than many expected in August, and producer inflation sank to the lowest level since February 2021, reports Reuters.
NIO Inc. stock is trending on the Yahoo Finance Platform. Here is a visualization of $NIO performance over time, how that performance compares to the wider industry, and analyst projections for the current quarter.Check out the ticker page here.
Peloton Interactive (NASDAQ: PTON) shares beat the market on Friday as the stock gained 11% by 1 p.m. ET compared to a 1.2% increase in the S&P 500. Shares have been reeling in recent months as Peloton struggled to boost sales of its exercise platforms or membership subscriptions to its services.
The S&P 500 is on again, off again all year. But investors clearly have a "buy list" of stocks they want to own when the rally looks real.
A strong bearish trend defined the markets in the first half of the year; since then, the key point has been volatility. Stocks hit a bottom back in June, when the S&P 500 dropped into the 3,600s. That has proven to be a support level in the last two months, and at least one strategist believes that the market won’t be testing those lows again this year. JPMorgan's Jason Hunter believes that inflation may have peaked, and that the upcoming CPI report will provide additional evidence of that. “We
Nursing homes and debt collectors are billing and suing long-term-care residents’ family members and friends, demanding payments for debts these individuals don’t legally owe, consumer attorneys and federal regulators are claiming. Under federal law, nursing homes participating in Medicare and Medicaid can’t make such provisions a condition of admission or continued stay in the facility.
Gary Gensler had strong words for the crypto industry in a Thursday speech, telling an audience of lawyers that the "vast majority" of the nearly 10,000 existing crypto tokens are securities.
The Dow Jones jumped as the rally gained strength. Tesla stock surged as Elon Musk eyed a new move. A Warren Buffett stock impressed.
In this article, we will look at 10 stocks that Jim Cramer is talking about in September. If you want to explore more stocks that journalist investor, Jim Cramer, is talking about in September, you can also take a look at Jim Cramer is Talking About These 5 Stocks in September. Jim Cramer has acquired […]
Investors are seeing higher growth potential for QuantumScape's battery cell technology after an interesting EV industry development.
All week long, trading in Nvidia (NASDAQ: NVDA) stock has been strong. After opening lower following the long holiday weekend, shares of the semiconductors-for-gaming leader have notched three straight days of stock price gains -- including this morning, with Nvidia stock up 2.2% through 10:30 a.m. ET. You can probably thank sustained buying by Cathie Wood for that.
Shares of AMC Entertainment (NYSE: AMC) are rising 8.7% higher at 10:13 a.m. ET on Friday following CEO Adam Aron thanking the movie theater operator's shareholders for their support as rival Cineworld (OTC: CNNW.F) filed for bankruptcy on Wednesday. It's been expected for some time that the Regal theater owner would eventually file, as the industry is still racked by low attendance, but Aron assured investors AMC is in a "very, very different situation." Although both theater operators have over $5 billion in debt, Aron maintains it was because of investors who rallied behind the stock over the past year that AMC doesn't find itself in a similar position.
On Friday, the company unveiled the Robinhood Investor Index, which captures how customers invest based on the top 100 most owned stocks on the platform.
See how to gauge demand and strength in Apple, Nasdaq and other stocks on the latest list of new buys by the best mutual funds.
The old saying “different strokes for different folks” certainly rings true in the stock market. Some investors prefer growth stocks like Tesla Inc. that are volatile but have produced years of outstanding appreciation. Other folks prefer less volatile stocks like Johnson & Johnson whose growth may be slower but also add dividends of 2% to 3% annually to the total performance. In addition, there are income investors, who strictly look for stocks that will provide high-yield dividends year after
Recently, Zacks.com users have been paying close attention to AT&T (T). This makes it worthwhile to examine what the stock has in store.
In this article, we discuss 10 dividend stocks with over 8% yield to buy in September. You can skip our detailed analysis of top high dividend stocks, and go directly to read 5 Best Dividend Stocks with Over 8% Yield You Can Buy in September. In the current market situation, investors are looking for different […]
FuelCell Energy (FCEL) posts wider-than-expected fiscal Q3 loss. FCEL's backlog remains strong and the company continues to deliver modules and meet customer needs through clean energy generation.